Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, L., Small molecule-based Life-span extension therapy: Cardiotrophin-1 (CT-1) extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 30/March/2014, 9.35 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Significance: It has been shown earlier that knocking down ADCY5/AC5 protects against diet-induced weight gain and insulin resistance. This study suggests, for the first time, that Cardiotrophin-1 (CT-1, by increasing the expression of its target gene, it may suppress the expression of ADCY5/AC5. Thereby, it may (1) promote insulin sensitivity; (2) prevent diet-induced weight gain; (3) and extend the lifespan of an individual. Thus, pharmacological formulations encompassing “Cardiotrophin-1 (CT-1 activators“ (that suppress the expression of ADCY5/AC5) may be used to extend the life-span of an an individual.
Undisclosed information: How Cardiotrophin-1 (CT-1) suppresses the expression of adenylate cyclase 5 (ADCY5)
